Last reviewed · How we verify

NCT03450811

Effect of Inguinal Hernia Repair on Uroflowmetric Parameteres

Completed NA Last updated 27 March 2018
What this trial tests

NA trial testing Inguinal hernia repair in Inguinal Hernia in 120 participants. Completed in 1 March 2018.

Timeline
1 January 2018
Primary endpoint
20 February 2018
1 March 2018

Quick facts

Lead sponsorAnkara Training and Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposediagnostic
Enrollment120
Start date1 January 2018
Primary completion20 February 2018
Estimated completion1 March 2018
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara Training and Research Hospital

Who can join

Adults 20 to 90, male only, with Inguinal Hernia or Urinary Retention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Post operative acute urinary retension or voiding dysfunction are complications after inguinal hernia repair and they cause a great deal of discomfort and stress to patients. Furthermore, they can also increase hospital costs by increasing hospital stay, and by growing the need for outpatient appointments after an elective surgical procedure. Some studies recommend prophylactic alpha blockers to minimizing these adverse effects. Investigators aimed to determine the changes of uroflowmetric values for male patients following elective inguinal hernia repair.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Inguinal hernia repair

Trials testing the same drug.

Other recruiting trials for Inguinal Hernia

Currently open trials in the same condition.

Other Ankara Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03450811.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing